Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial.
Hee-Je KimHyun-Jung SohnJung-A HongHyun-Joo LeeDae-Hee SohnChang-Ae ShinHyun-Il ChoWoo-Sung MinTai-Gyu KimPublished in: Bone marrow transplantation (2018)